HomeAI · summaries
Storia in 3 fonti
Africa’s most developed pharmaceutical market reviews 12 Ozempic generics as drugmakers target Novo Nordisk’s dominance
South Africa is reviewing 12 generic semaglutide applications after Novo Nordisk’s patent expired, opening a price battle over Ozempic and Africa’s fast-growing GLP-1 market
Confronto fonti
3 prospettive sulla stessa storiaTimeline cronologica
- ·
businessday.co.za
Novo Nordisk to launch cheaper Ozempic copy in South Africa
Novo Nordisk will launch Extensior, a cheaper Ozempic copy, in South Africa on July 27
- ·
africa.businessinsider.com
Africa’s most developed pharmaceutical market reviews 12 Ozempic generics as drugmakers target Novo Nordisk’s dominance
South Africa is reviewing 12 generic semaglutide applications after Novo Nordisk’s patent expired, opening a price battle over Ozempic and Africa’s fast-growing GLP-1 market
